期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 286, 期 44, 页码 37919-37931出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.251777
关键词
-
资金
- British Heart Foundation [FS/06/22]
- National Health Service
- Cancer Research UK [C309/A8274]
- Institute of Cancer Research
- Cancer Research UK [11566] Funding Source: researchfish
VEGF is a key angiogenic cytokine and a major target in antiangiogenic therapeutic strategies. In endothelial cells (ECs), VEGF binds VEGF receptors and activates ERK1/2 through the phospholipase gamma (PLC gamma)-PKC alpha-B-Raf pathway. Our previous work suggested that influx of extracellular Ca2+ is required for VEGF-induced ERK1/2 activation, and we hypothesized that this could occur through reverse mode (Ca2+ in and Na+ out) Na+-Ca2+ exchange (NCX). However, the role of NCX activity in VEGF signaling and angiogenic functions of ECs had not previously been described. Here, using human umbilical vein ECs (HUVECs), we report that extracellular Ca2+ is required for VEGF-induced ERK1/2 activation and that release of Ca2+ from intracellular stores alone, in the absence of extracellular Ca2+, is not sufficient to activate ERK1/2. Furthermore, inhibitors of reverse mode NCX suppressed the VEGF-induced activation of ERK1/2 in a time-and dose-dependent manner and attenuated VEGF-induced Ca2+ transients. Knockdown of NCX1 (the main NCX isoform in HUVECs) by siRNA confirmed the pharmacological data. A panel of NCX inhibitors also significantly reduced VEGF-induced B-Raf activity and inhibited PKC alpha translocation to the plasma membrane and total PKC activity in situ. Finally, NCX inhibitors reduced VEGF-induced HUVEC proliferation, migration, and tubular differentiation in surrogate angiogenesis functional assays in vitro. We propose that Ca2+ influx through reverse mode NCX is required for the activation and the targeting of PKC alpha to the plasma membrane, an essential step for VEGF-induced ERK1/2 phosphorylation and downstream EC functions in angiogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据